4-Aminomethyltetrahydropyran → 6-Bromo-3-chloro-N-((tetrahydro-2H-pyran-4-yl)methyl)pyrazin-2-amine

HRID 1623379

Reaktionsgleichung

Reaktionsgleichung von HRID 1623379
Br[C:2]1[C:3]([Cl:9])=[N:4][CH:5]=[C:6]([Br:8])[N:7]=1.[O:10]1[CH2:15][CH2:14][CH:13]([CH2:16][NH2:17])[CH2:12][CH2:11]1>CC#N>[Br:8][C:6]1[N:7]=[C:2]([NH:17][CH2:16][CH:13]2[CH2:14][CH2:15][O:10][CH2:11][CH2:12]2)[C:3]([Cl:9])=[N:4][CH:5]=1

Komponenten

4

Reaktionsbedingungen

Temperatur
80 °C

Versuchsvorschrift

To a scintillation vial containing 3,5-dibromo-2-chloropyrazine (1 g, 3.67 mmol) and TEA (1.024 ml, 7.34 mmol) was added MeCN (5 ml) and (tetrahydro-2H-pyran-4-yl)methanamine (0.557 g, 3.67 mmol). The homogenous reaction mixture was capped, and heated to 80° C. in a oil bath for 4 hr. The reaction mixture was concentrated to dryness, diluted with EtOAc and sequentially washed with sat NaHCO3, and sat NaCl. The organic layer was dried Na2SO4, filtered and concentrated. The crude was purified by column chromatography on silica gel (20% EtOAc/Hexane) to yield 6-bromo-3-chloro-N-((tetrahydro-2H-pyran-4-yl)methyl)pyrazin-2-amine (688 mg, 2.244 mmol, 61.1% yield), yield), LCMS (m/z): 308.0 (MH+), retention time=0.94 min, and 6-bromo-5-chloro-N-((tetrahydro-2H-pyran-4-yl)methyl)pyrazin-2-amine (55 mg, 0.179 mmol, 4.89% yield), LCMS (m/z): 308.0 (MH+), retention time=0.91 min.

Aufarbeitung

  1. customThe homogenous reaction mixture was capped
  2. concentrationThe reaction mixture was concentrated to dryness
  3. additiondiluted with EtOAc
  4. washsequentially washed with sat NaHCO3
  5. filtrationfiltered
  6. concentrationconcentrated
  7. customThe crude was purified by column chromatography on silica gel (20% EtOAc/Hexane)

Quellen und Nachweise

ORD-Eintrag
ord-e940e6cdfc8e4cea8744fb038615e0ee
Quelldatensatz
uspto-grants-2014_07
Patentnummer
US08778951B2

Verknüpfte Notizen

Wird geladen…